Detalhe da pesquisa
1.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653053
2.
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Clin Cancer Res
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771739
3.
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
Ther Adv Med Oncol
; 14: 17588359221087555, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35432603
4.
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.
Lancet Gastroenterol Hepatol
; 6(12): 1025-1035, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34695377
5.
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250396
6.
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.
J Thorac Oncol
; 15(12): 1928-1934, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32866654
7.
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial.
Clin Cancer Res
; 24(21): 5272-5281, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045931
8.
Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right?
Ann Transl Med
; 8(24): 1692, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33490204